Stefania Spila Alegiani

Author

Also Known As

Angela Giusti, Antonietta Elia, E. Mannucci, ITA-COVID-19: RAAS inhibitor group, Marta Ciofi degli Atti, S S Alegiani, S Spila Alegiani, S Spila-Alegiani, S. Spila Alegiani, S. Spila-Alegiani

119

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Istituto Superiore di Sanità Regione Lombardia Regione del Veneto University of Messina Ministero della Salute

About

Stefania Spila Alegiani is an author at Istituto Superiore di Sanità specializing in medicine, epidemiology, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	288
2	Epidemiology	7	7	215
3	Public Health	6	6	176
4	Health Sciences	2	2	59
5	Culture	1	1	12

Stefania Spila Alegiani

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Incidence of Coronary Heart Disease in Type 2 Diabetic Men and Women Angelo Avogaro, Carlo Giorda, Marina Maggini, Diabetes Care	2007	158
Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study Massimo Fabiani, Maria Puopolo, Cristina Morciano, BMJ	2022	115
Incidence and Risk Factors for Stroke in Type 2 Diabetic Patients Carlo Giorda, Angelo Avogaro, Marina Maggini, Stroke	2007	113
Recurrence of Cardiovascular Events in Patients With Type 2 Diabetes Carlo Giorda, Angelo Avogaro, Marina Maggini, Diabetes Care	2008	88
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia Francesco Menichetti, Patrizia Popoli, Maria Puopolo, JAMA Network Open	2021	66
<p>Survival of Hospitalized COVID-19 Patients in Northern Italy: A Population-Based Cohort Study by the ITA-COVID-19 Network</p> Eliana Ferroni, Paolo Giorgi Rossi, Stefania Spila Alegiani, Clinical Epidemiology	2020	59
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients Gianluca Trifirò, Marco Massari, Roberto Da, Drug Safety	2020	55
Mortality cancer risk in parkinsonian patients: A population-based study Nicola Vanacore, Stefania Spila Alegiani, Roberto Raschetti, Neurology Italian ProvinceEpidemiology Of CancerPopulation Health SciencesCancer Risk FactorsLogistic Analysis	1999	54
Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study Marco Massari, Stefania Spila Alegiani, Cristina Morciano, PLoS Medicine	2022	50
Evaluation of safety of A/H1N1 pandemic vaccination during pregnancy: cohort study Francesco Trotta, Stefania Spila Alegiani, Maria Gramegna, BMJ	2014	49

Page 1